Franky Vargas, Enrique Institutions of which they are part Research technician Molecular Medical Imaging Vall Hebron Institut de Recerca Email Franky Vargas, Enrique Email Institutions of which they are part Research technician Molecular Medical Imaging Vall Hebron Institut de Recerca
Projects Resistencia a la insulina en la diabetes tipo 2: clarificando el mecanismo patogénico de la resistencia a la insulina miocárdica y los efectos de tratamientos con GLP-1 RA y SGLT2i IP: José Raul Herance Camacho Collaborators: Sofia Rodriguez Fernandez, Sergi Velasco Vila, Clara Ramírez Serra, Azahara Maria Palomar Muñoz, Cristina Gamez Cenzano, Jana Vidal Otero, Carolina Aparicio Gomez, Alberto Roque Pérez, Queralt Martin Saladich, Julia Baguña Torres, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán, Maria Nazarena Pizzi, Emily Betancourt Fernández, Enrique Franky Vargas, Eser Ucar, Martha Sahylí Ortega Pijeira Funding agency: Instituto de Salud Carlos III Funding: 252500 Reference: PI24/01356 Duration: 01/01/2025 - 31/12/2027 ARTEMIs: AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients IP: José Raul Herance Camacho Collaborators: Beatriz Minguez Rosique, Clara Ramírez Serra, Cristina Gamez Cenzano, Juan Manuel Pericàs Pulido, Nuria Roson Gradaille, Andreea Ciudin Mihai, Alberto Roque Pérez, Queralt Martin Saladich, Maria Nazarena Pizzi, Ramón Vilallonga Puy, Enrique Franky Vargas Funding agency: EUROPEAN COMMISSION Funding: 724000 Reference: ARTEMIS_HE-HLTH2023 Duration: 01/01/2024 - 31/12/2027 Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia IP: Rafael Simó Canonge Collaborators: Marina Jimenez Iglesias, Cristina Hernández Pascual, Queralt Martin Saladich, Patricia Bogdanov Baruj, Andreea Ciudin Mihai, Ferran Casals Riera, Maddalen Zufiaurre Seijo, Enrique Franky Vargas, José Raul Herance Camacho, Ingrid Balcells Ortega, Marco Inzitari Funding agency: EUROPEAN COMMISSION Funding: 974782.7 Reference: RECOGNISED_H2020SC1BHC2019 Duration: 01/01/2020 - 31/12/2024
